SYRE · Spyre Therapeutics, Inc. · Proposed Sales
$99.48
-0.27 (-0.27%)
At close · Oct 29
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital to continue to fund our operations in the future. If we are unable to raise additional capital when needed, we will not be able to continue as a going concern.”View the 10-Q filed Aug 4, 2026
Market Cap
$8.72B
Shares
88.17M
Volume · Oct 29
126.04K
Avg daily vol (3M)
1.21M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-10-01 | CAMERON TURTLE | Director, Officer | 45,000 | 2026-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-10-01 | HEIDY KING-JONES | Officer | 29,335 | 2026-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-30 | SCOTT BURROWS | Officer | 17,500 | 2026-09-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | HEIDY KING-JONES | Officer | 46,665 | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | SESSIONS, LLC | Director | 18,000 | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | JEFFREY ALBERS | Director | 5,000 | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | SCOTT BURROWS | Officer | 30,000 | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-01 | CAMERON TURTLE | Director, Officer | 45,000 | 2026-07-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-25 | SCOTT BURROWS | Officer | 15,000 | 2026-06-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-23 | Fairmount Healthcare Fund II L.P. | Director | 4,684,781 | 2026-06-23 | Goldman Sachs & Co. LLC |
| 2026-06-22 | MICHAEL HENDERSON | Director | 20,000 | 2026-06-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-03 | SHELDON SLOAN | Officer | 16,667 | 2026-06-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-08 | MICHAEL HENDERSON | Director | 80,000 | 2026-05-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-01 | SCOTT BURROWS | Officer | 27,500 | 2026-05-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-01 | SHELDON SLOAN | Officer | 78,333 | 2026-05-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-01 | SHELDON SLOAN | Officer | 7,958 | 2026-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-03 | SCOTT BURROWS | Officer | 10,000 | 2026-03-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | CAMERON TURTLE | Director, Officer | 60,000 | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-03 | CAMERON TURTLE | Director, Officer | 90,000 | 2025-11-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-10-25 | SESSIONS, LLC | Director | 7,000 | 2024-10-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–20 of 20 filings
Key facts
CIK
1636282
CUSIP
00773J202
13F (30d)
31 filings
31 filers
Visit website
Investor relations